Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

29 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Aggressive lymphoma subtype is a risk factor for venous thrombosis. Development of lymphoma - specific venous thrombosis prediction models.
Dharmavaram G, Cao S, Sundaram S, Ayyappan S, Boughan K, Gallogly M, Malek E, Metheny L, Tomlinson B, Otegbeye F, Lazarus HM, Cooper B, Fu P, de Lima M, Caimi PF. Dharmavaram G, et al. Among authors: gallogly m. Am J Hematol. 2020 Aug;95(8):918-926. doi: 10.1002/ajh.25837. Epub 2020 May 8. Am J Hematol. 2020. PMID: 32311162 Free article.
Treatment-related mortality following autologous hematopoietic stem cell transplantation is unaffected by timing of G-CSF administration.
Ali N, Cooper B, Tomlinson B, Metheny L, Caimi P, Boughan K, Gallogly M, Otegbeye F, Malek E, Lazarus H, Creger R, de Lima M. Ali N, et al. Among authors: gallogly m. Bone Marrow Transplant. 2020 Aug;55(8):1697-1700. doi: 10.1038/s41409-020-0812-x. Epub 2020 Feb 5. Bone Marrow Transplant. 2020. PMID: 32024994 No abstract available.
A Phase II Study of Midostaurin and 5-Azacitidine for Untreated Elderly and Unfit Patients With FLT3 Wild-type Acute Myelogenous Leukemia.
Tomlinson BK, Gallogly MM, Kane DM, Metheny L, Lazarus HM, William BM, Craig MD, Levis MJ, Cooper BW. Tomlinson BK, et al. Among authors: gallogly mm. Clin Lymphoma Myeloma Leuk. 2020 Apr;20(4):226-233.e1. doi: 10.1016/j.clml.2019.10.018. Epub 2019 Nov 6. Clin Lymphoma Myeloma Leuk. 2020. PMID: 32085993 Clinical Trial.
Influence of gut microbiome on multiple myeloma: friend or foe?
Ahmed N, Ghannoum M, Gallogly M, de Lima M, Malek E. Ahmed N, et al. Among authors: gallogly m. J Immunother Cancer. 2020 Jun;8(1):e000576. doi: 10.1136/jitc-2020-000576. Epub 2020 Jun 23. J Immunother Cancer. 2020. PMID: 32581045 Free PMC article.
History of drug use in allogeneic hematopoietic cell transplant recipients.
Abou-Ismail MY, Ravi G, Fu P, Cao S, Vuyyala S, Caimi P, Kolk M, Ferrari N, Boughan K, Cooper B, Gallogly M, Otegbeye F, Tomlinson B, de Lima M, Metheny L. Abou-Ismail MY, et al. Among authors: gallogly m. Bone Marrow Transplant. 2021 Mar;56(3):581-585. doi: 10.1038/s41409-020-01058-z. Epub 2020 Sep 17. Bone Marrow Transplant. 2021. PMID: 32943757
Correction: History of drug use in allogeneic hematopoietic cell transplant recipients.
Abou-Ismail MY, Ravi G, Fu P, Cao S, Vuyyala S, Caimi P, Kolk M, Ferrari N, Boughan K, Cooper B, Gallogly M, Otegbeye F, Tomlinson B, de Lima M, Metheny L. Abou-Ismail MY, et al. Among authors: gallogly m. Bone Marrow Transplant. 2021 Mar;56(3):756. doi: 10.1038/s41409-020-01085-w. Bone Marrow Transplant. 2021. PMID: 33087878 No abstract available.
29 results